glp-1 and celiac disease Gut Health: Addressing Metabolic Dysfunction for Physicians Potential mechanisms of weight loss

Michael Wasef, MD Medical Director Wasef Health, PC Board-certified physician with over 15 years of experience in internal medicine and telehealth

Figure 3 presents a diagnostic algorithm for SID and SIH based on the present medical history and laboratory markers of diabetes

Final Takeaway Whether GLP-1 medication is used or not, long-term metabolic health depends on one foundation : A resilient microbiome healthy SCFAs stable GLP-1 lasting metabolic balance

Finally, pancreatic stellate cells (Figure 3v) were always found to be GLP1R negative (Figure 3w)

The streamlined approach is expected to set a new precedent for future litigation involving large numbers of plaintiffs

Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity